RDY
Dr. Reddy's Laboratories LtdStock · Health Care$12.28−$0.14 (-1.13%)as of market close, Aug 14, 2026
☾ After hours:$12.27+0.00%3:59 PM ET
RDY — Dr. Reddy's Laboratories Ltd stock price, chart and key statistics
Key stats#
Price data
- Price
- $12.28
- Change YTD
- -11.92%
- Market cap
- 10.2B
- Enterprise value
- 10.3B
- Shares outstanding
- 834.7M
- 52W low
- $11.36
- 52W high
- $15.67
- From 52W high
- -21.63%
- From 52W low
- +8.10%
- 52W range
- 21%
- Beta
- 0.28
Volume
- Rel volume
- 0.71×
- 30D volume
- 2.8M
- 30D $ vol
- 35.2M
Fundamentals
- Sales (ttm)
- 3.6B
- Sales/share
- $4.29
- EPS (ttm)
- $0.55
- FCF (ttm)
- 607M
- FCF/share
- $0.73
- Book value/share
- $4.81
- Net margin
- 12.63%
- ROE
- 11.25%
- ROA
- 7.32%
- Debt / equity
- 0.03×
- Current ratio
- 1.80
Growth (CAGR, ttm) · 10Y
- Sales
- n/a
- Net income
- n/a
- Shares
- n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- n/a
- Book value/share
- n/a
- Dividend/share
- n/a
- Price
- +3.20%
- Total return
- +4.00%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- 22.3×
- 19.0×
- Fwd P/E
- 19.1×
- 2.9×
- 2.6×
- 16.9×
- EV/EBITDA (fy)
- 13.3×
- EV/Sales (ttm)
- 2.9×
- 5.92%
- 0.74%
- Dividend/share (fwd)
- $0.09
- -0.02%
- 0.66%
- 0.00%
- 0.73%
Vs own 10Y history
- P/E
- 33rd
- P/OI
- 33rd
- P/S
- 19th
- P/B
- 2nd
Bar = where today's multiple sits in RDY's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return#
1D
-1.13%
1W
+0.49%
1M
-2.63%
3M
-8.33%
YTD
-11.92%
1Y
-13.28%
5Y
-0.47%
Financial statements
Open full RDY financials →Related Health Care#
1MDr. Reddy's Laboratories Ltd (RDY) trades at $12.28 with a live price and an interactive chart covering 25+ years of daily price history, plus key valuation metrics. ChartRow also publishes RDY's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full RDY financial statements →
